

Metastatic prostate cancer, approved by Laos FDD, authoritative certification, Laos Element Pharmaceutical Apalutamide 60mg 120 tablets
For the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) with a high risk of metastasis.
60mg*120 tablets/box is suitable for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) with a high risk of metastasis.
Indications:
Recommended dose: {For reference only, follow the doctor's advice} The recommended dose is 240 mg (4 tablets), once a day, orally. It can be taken alone or with food. The whole tablet should be swallowed with water. If you miss 1 dose of medication, you should take the medication as soon as possible on the same day, and take the medication as planned the next day. Do not take extra to make up for the missed dose.


